Learn how to integrate market access insights into pharma brand strategies.
Abigail Ahearn helps clients to develop, enhance and evaluate their marketing and communications strategies. She has 25+ years of experience across industries with a particular emphasis on pharmaceuticals and healthcare. While classically trained in quantitative and qualitative market research, Abbey finds that engagements are often strengthened by other means of insights generation at which she excels, including workshops, executive interviews, and secondary research synthesis. Abbey is often recognized for being creative and forward-thinking in her approach to client questions, especially as a shift towards value-based care and payment has demanded new ways of approaching healthcare marketing.
Prior to joining HawkPartners, Abbey served in multiple client service roles at global research firm Ipsos, including research manager for Ipsos-Far East in Hong Kong where she led quantitative advertising and brand research projects for Fortune 500 clients in China, Japan and the Philippines. Abbey has also managed marketing research initiatives for Allianz AG as well as consulted for United Way International and the General Motors Foundation where she facilitated partnerships between corporations and nonprofits. Early in her career, Abbey produced content and initiated marketing research efforts for Scholastic’s online service for K-12 schools.
Outside of work, Abbey enjoys spending time with her family, including two children, and training for triathlons. She craves being active outside and has been known to disappear on her gravel bike to the backroads of Colorado and Texas.
Abigail received a BA from Dartmouth College and MBA from the University of Michigan’s Ross School of Business.
Perspectives by Abigail Ahearn
The current pandemic is tearing down the regulatory and reimbursement barriers that have prevented telehealth from realizing its full potential to date. Our team examines the value propositions of several telehealth providers as the industry enters the next stage of growth.
Statistics and investments point to pharma companies’ integration of transformative technologies into ways of thinking and doing business. The infographic below, developed by Abbey Ahearn and Lucy Hale, demonstrates the rising emphasis of digital health in pharma.
Amidst explosive investment in digital health, the industry is working to keep the human side of care front and center.
Abbey Ahearn shares her vision on the (near-term) future of consumer healthcare. Pills with sensors, digital therapeutics for addiction, and AI for early cancer detection are just a few of the coming innovations.
Discover 5 keys to giving customers compelling reasons to use artificial intelligence to enhance customer experiences